These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1259 related items for PubMed ID: 12730770

  • 1. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
    Seeman E.
    Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bone fragility: failure of periosteal apposition to compensate for increased endocortical resorption in postmenopausal women.
    Szulc P, Seeman E, Duboeuf F, Sornay-Rendu E, Delmas PD.
    J Bone Miner Res; 2006 Dec; 21(12):1856-63. PubMed ID: 17002580
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Invited Review: Pathogenesis of osteoporosis.
    Seeman E.
    J Appl Physiol (1985); 2003 Nov; 95(5):2142-51. PubMed ID: 14555675
    [Abstract] [Full Text] [Related]

  • 10. A theoretical analysis of long-term bisphosphonate effects on trabecular bone volume and microdamage.
    Nyman JS, Yeh OC, Hazelwood SJ, Martin RB.
    Bone; 2004 Jul; 35(1):296-305. PubMed ID: 15207770
    [Abstract] [Full Text] [Related]

  • 11. [Rational bases for the treatment of osteoporosis].
    Adami S, Bianchini D, Zanfisi C, Fracassi E, Galvanini G.
    Ann Ital Med Int; 1995 Oct; 10 Suppl():18S-21S. PubMed ID: 8562260
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Thinking inside and outside the envelopes of bone: dedicated to PDD.
    Szulc P, Seeman E.
    Osteoporos Int; 2009 Aug; 20(8):1281-8. PubMed ID: 19590836
    [Abstract] [Full Text] [Related]

  • 14. Age- and menopause-related bone loss compromise cortical and trabecular microstructure.
    Seeman E.
    J Gerontol A Biol Sci Med Sci; 2013 Oct; 68(10):1218-25. PubMed ID: 23833200
    [Abstract] [Full Text] [Related]

  • 15. Minimodeling reduces the rate of cortical bone loss in patients with secondary hyperparathyroidism.
    Yajima A, Inaba M, Tominaga Y, Ito A.
    Am J Kidney Dis; 2007 Mar; 49(3):440-51. PubMed ID: 17336706
    [Abstract] [Full Text] [Related]

  • 16. Bone histomorphometry in the pathophysiological evaluation of primary and secondary osteoporosis and various treatment modalities.
    Steiniche T.
    APMIS Suppl; 1995 Mar; 51():1-44. PubMed ID: 7669370
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Osteoporosis. Efficacy and safety of a bisphosphonate dosed once weekly.
    Baran D.
    Geriatrics; 2001 Mar; 56(3):28-32. PubMed ID: 11252758
    [Abstract] [Full Text] [Related]

  • 19. Primary hyperparathyroidism: lessons from bone histomorphometry.
    Eriksen EF.
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N95-7. PubMed ID: 12412784
    [Abstract] [Full Text] [Related]

  • 20. Effects of intermittent hPTH(1-34) alone and in combination with 1,25(OH)(2)D(3) or risedronate on endosteal bone remodeling in canine cancellous and cortical bone.
    Boyce RW, Paddock CL, Franks AF, Jankowsky ML, Eriksen EF.
    J Bone Miner Res; 1996 May; 11(5):600-13. PubMed ID: 9157775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.